HTA184 Investigating How Orphan Drug Manufacturers Can Optimize Clinical Trial Design so Patients across Geographies Can Access Life-Saving Innovations
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1642
https://www.valueinhealthjournal.com/article/S1098-3015(22)03847-5/fulltext
Title :
HTA184 Investigating How Orphan Drug Manufacturers Can Optimize Clinical Trial Design so Patients across Geographies Can Access Life-Saving Innovations
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03847-5&doi=10.1016/j.jval.2022.09.1642
First page :
Section Title :
Open access? :
No
Section Order :
11195